Epigenetic dysregulation in cognitive disorders

被引:107
|
作者
Graeff, Johannes
Mansuy, Isabelle M. [1 ]
机构
[1] Univ Zurich, Brain Res Inst, Fac Med, Zurich, Switzerland
基金
瑞士国家科学基金会;
关键词
epigenetic codes; neurodegeneration; neurodevelopment; reversibility; schizophrenia; RUBINSTEIN-TAYBI-SYNDROME; HISTONE DEACETYLASE INHIBITORS; LONG-TERM-MEMORY; DNA METHYLATION; MOUSE MODEL; HUNTINGTONS-DISEASE; SYNAPTIC PLASTICITY; ACETYLTRANSFERASE ACTIVITY; GENETIC-HETEROGENEITY; ALZHEIMERS-DISEASE;
D O I
10.1111/j.1460-9568.2009.06787.x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Epigenetic mechanisms are not only essential for biological functions requiring stable molecular changes such as the establishment of cell identity and tissue formation, they also constitute dynamic intracellular processes for translating environmental stimuli into modifications in gene expression. Over the past decade it has become increasingly clear that both aspects of epigenetic mechanisms play a pivotal role in complex brain functions. Evidence from patients with neurodegenerative and neurodevelopmental disorders such as Alzheimer's disease and Rett syndrome indicated that epigenetic mechanisms and chromatin remodeling need to be tightly controlled for proper cognitive functions, and their dysregulation can have devastating consequences. However, because they are dynamic, epigenetic mechanisms are also potentially reversible and may provide powerful means for pharmacological intervention. This review outlines major cognitive disorders known to be associated with epigenetic dysregulation, and discusses the potential of 'epigenetic medicine' as a promising cure.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 50 条
  • [1] Neurodevelopmental disorders with epigenetic dysregulation and Drosophila
    Cho, Kyoung Sang
    Song, Bokyeong
    Lee, Im-Soon
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2019, 24 : 1330 - 1349
  • [2] Epigenetic Dysregulation of Dopaminergic Genes in Eating Disorders
    Frieling, Helge
    Roemer, Konstanze D.
    Scholz, Sarah
    Mittelbach, Franziska
    Wilhelm, Julia
    De Zwaan, Martina
    Jacoby, Georg E.
    Kornhuber, Johannes
    Hillemacher, Thomas
    Bleich, Stefan
    INTERNATIONAL JOURNAL OF EATING DISORDERS, 2010, 43 (07) : 577 - 583
  • [3] Targeting epigenetic dysregulation in autism spectrum disorders
    Herrera, Macarena L.
    Paraiso-Luna, Juan
    Bustos-Martinez, Isabel
    Barco, Angel
    TRENDS IN MOLECULAR MEDICINE, 2024, 30 (11) : 1028 - 1046
  • [4] Epigenetic Drugs in Cognitive Disorders
    Peedicayil, Jacob
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (11) : 1840 - 1846
  • [5] EPIGENETIC REGULATION IN MEMORY AND COGNITIVE DISORDERS
    Rudenko, A.
    Tsai, L-H
    NEUROSCIENCE, 2014, 264 : 51 - 63
  • [6] MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction
    Xu, Bin
    Hsu, Pei-Ken
    Karayiorgou, Maria
    Gogos, Joseph A.
    NEUROBIOLOGY OF DISEASE, 2012, 46 (02) : 291 - 301
  • [7] Preterm Birth and the Risk of Neurodevelopmental Disorders - Is There a Role for Epigenetic Dysregulation?
    Fitzgerald, Eamon
    Boardman, James P.
    Drake, Amanda J.
    CURRENT GENOMICS, 2018, 19 (07) : 507 - 521
  • [8] Maternal Epigenetic Dysregulation as a Possible Risk Factor for Neurodevelopmental Disorders
    Lintas, Carla
    Cassano, Ilaria
    Azzara, Alessia
    Stigliano, Maria Grazia
    Gregorj, Chiara
    Sacco, Roberto
    Stoccoro, Andrea
    Coppede, Fabio
    Gurrieri, Fiorella
    GENES, 2023, 14 (03)
  • [9] Perinatal Epigenetic Determinants of Cognitive and Metabolic Disorders
    Lupu, Daniel S.
    Tint, Diana
    Niculescu, Mihai D.
    AGING AND DISEASE, 2012, 3 (06): : 444 - 453
  • [10] The Treatments of Depressive Disorders/Cognitive Dysregulation With Dietary Phytosterols
    Mooney, John J.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2022, 42 (01) : 112 - 113